Cargando…

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma

The tumor microenvironment (TME) influences disease initiation and progression. Cross-talks of cells within TME can affect the efficacy of immunotherapies. However, a precise, concise, and comprehensive TME landscape in neuroblastoma (NB) has not been established. Here, we profiled the TME landscape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Chenzhao, Li, Ting, Xiao, Jun, Wang, Jing, Meng, Xinyao, Niu, Huizhong, Jiang, Bin, Huang, Lei, Deng, Xiaogeng, Yan, Xueqiang, Wu, Dianming, Fang, Yifan, Lin, Yu, Chen, Feng, Wu, Xiaojuan, Zhao, Xiang, Feng, Jiexiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047956/ https://www.ncbi.nlm.nih.gov/pubmed/35493068 http://dx.doi.org/10.3389/fcell.2022.814836

Ejemplares similares

Combined analysis of RNA‐sequence and microarray data reveals effective metabolism‐based prognostic signature for neuroblastoma
por: Meng, Xinyao, et al.
Publicado: (2020)

A Deep-Learning Model With the Attention Mechanism Could Rigorously Predict Survivals in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2021)

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
por: Wang, Jing, et al.
Publicado: (2022)

Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis
por: Meng, Xinyao, et al.
Publicado: (2020)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma
por: Meng, Xinyao, et al.
Publicado: (2020)

Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma
por: Sha, Yongliang, et al.
Publicado: (2022)

The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021)

Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn’s disease
por: Wang, Jing, et al.
Publicado: (2022)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment
por: Fu, Denggang, et al.
Publicado: (2023)

Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma
por: Zheng, Chen, et al.
Publicado: (2020)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
por: Morandi, Fabio, et al.
Publicado: (2018)

Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
por: Morandi, Fabio, et al.
Publicado: (2021)

Ferroptosis-related gene signatures in neuroblastoma associated with prognosis
por: Chen, Yiru, et al.
Publicado: (2022)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020)

Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer
por: Dai, Shuang, et al.
Publicado: (2021)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020)

Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures
por: Huo, Mengqi, et al.
Publicado: (2020)

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
por: Zhang, Simeng, et al.
Publicado: (2021)

Pyroptosis-Related Signature and Tumor Microenvironment Infiltration Characterization in Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2022)

A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response
por: Yang, Jiaxing, et al.
Publicado: (2022)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Chu, Guangdi, et al.
Publicado: (2021)

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
por: Zhang, Wenshuo, et al.
Publicado: (2022)

Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature
por: Zhang, Pengpeng, et al.
Publicado: (2023)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent
por: Chen, Jia-Hong, et al.
Publicado: (2021)

The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
por: Zhang, Yong, et al.
Publicado: (2022)

COVID-19: benefits and risks of passive immunotherapeutics
por: Gupta, Ankur, et al.
Publicado: (2020)

Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
por: Liu, Senbo, et al.
Publicado: (2023)

A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
por: Li, Yue, et al.
Publicado: (2022)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Bao, Xuanwen, et al.
Publicado: (2019)

Refining immunotherapeutic approaches to high‐risk neuroblastoma based on tumor genomic profiles
por: Grossmann, Liron D., et al.
Publicado: (2020)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a7l3t2of1lbcbcd521q7srjql5